| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |